Changes

Adverse reactions to drugs including lack of expected efficacy occurring in the United Kingdom should be reported to the [[Drug Legislation| Veterinary Medicines Directorate (VMD)]] on their form MLA252A. Adverse events occurring in other European Union (EU) Member States, Norway, Iceland and Liechtenstein, should be reported to the relevant competent authority where the event occurred using the [http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000176.jsp&mid=WC0b01ac058002ddcb/ EU reporting forms for veterinarians] which are available in each EU language on the [http://www.ema.europa.eu/ European Medicines Agency] website.

Adverse reactions to drugs including lack of expected efficacy occurring in the United Kingdom should be reported to the [[Drug Legislation| Veterinary Medicines Directorate (VMD)]] on their form MLA252A. Adverse events occurring in other European Union (EU) Member States, Norway, Iceland and Liechtenstein, should be reported to the relevant competent authority where the event occurred using the [http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000176.jsp&mid=WC0b01ac058002ddcb/ EU reporting forms for veterinarians] which are available in each EU language on the [http://www.ema.europa.eu/ European Medicines Agency] website.

The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other veterinary medicine-related problem is called veterinary pharmacovigilance. Further information on veterinary pharmacovigilance in the European Union, is available via the [http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000190.jsp&mid=WC0b01ac058002d89c/ European Medicines Agency] and [http://eudravigilance.ema.europa.eu/veterinary/index.html EudraVigilance Veterinary] websites.

The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other veterinary medicine-related problem is called [[Pharmacovigilance|veterinary pharmacovigilance]]. Further information on [[Pharmacovigilance|veterinary pharmacovigilance]] in the European Union, is available via the [http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000190.jsp&mid=WC0b01ac058002d89c/ European Medicines Agency] and [http://eudravigilance.ema.europa.eu/veterinary/index.html EudraVigilance Veterinary] websites.

==Literature Search==

==Literature Search==